Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other Countries
Health Technology Assessment in the United Kingdom
Health Technology Assessment and Comparative Effectiveness in Sweden
Conditionally Funded Field Evaluations
Comparative Assessment for Medications and Devices
Contemporary Challenges in Deriving Summary Estimates of Comparative Effectiveness Using Meta-Analysis
Reflecting Heterogeneity in Patient Benefits
Transportability of Comparative Effectiveness and Cost-Effectiveness between Countries
Experimental and Observational Data and Formulary Listing
Net Clinical Benefit